Childhood Acute Megakaryocytic Leukemia (M7) Completed Phase 2 Trials for Methotrexate (DB00563)

IndicationStatusPhase
DBCOND0028563 (Childhood Acute Megakaryocytic Leukemia (M7))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01177371High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaTreatment